(Q62040387)

English

Subcutaneous Hydrocortisone Children With Congenital Adrenal Hyperplasia

clinical trial

In more languages

edit

Statements

instance of

clinical trial

0 references

title

Interval Bolus Delivery of Subcutaneous Hydrocortisone Via Infusion Pump in Children With Congenital Adrenal Hyperplasia (English)

0 references

medical condition

hyperplasia

0 references

country

United States of America

0 references

start time

1 January 2019

0 references

end time

1 January 2020

0 references

number of participants

8

0 references

research intervention

hydrocortisone acetate

0 references

hydrocortisone hemisuccinate

0 references

Hydrocortisone / Neomycin / Polymyxin B

0 references

Glucocorticoids in hippocampal development

0 references

(±)-adrenaline

0 references

racepinephrine hydrochloride

0 references

epinephryl borate

0 references

clinical trial phase

phase I clinical trial

0 references

phase II clinical trial

0 references

research site

Prism Clinical Research

0 references

research subject recruitment status

recruiting

0 references

study type

interventional study

0 references

Identifiers

ClinicalTrials.gov ID

NCT03718234

0 references

(Q62040387)

Subcutaneous Hydrocortisone Children With Congenital Adrenal Hyperplasia

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)